New discoveries and advancements in science have helped Americans live longer, healthier, and more productive lives. As the administration and Congress explore ways to further align public policy with medical innovation and patient access to new medicines and devices, the Bipartisan Policy Center launches a new initiative focused on developing strategies to advance medical innovation within the Food and Drug Administration.

On Monday, March 16, government and private sector experts will discuss the actions needed to accelerate the discovery, development and delivery of medical products. Such products will save and improve patients’ lives, reduce the burden of chronic disease, and maintain our nation’s global competitiveness in medical innovation.

Join the conversation on Twitter: @BPC_Bipartisan #BPClive